Progression of Parkinson's disease follows brain connectivity

January 12, 2018, McGill University
Progression of Parkinson's disease follows brain connectivity
Credit: McGill University

A study by a group of researchers including those from The Montreal Neurological Institute and Hospital of McGill University has tested the theory that brain degeneration in Parkinson's disease (PD) originates in subcortical regions and spreads along neural networks to the cerebral cortex.

By analyzing data on PD patients and healthy controls collected over one year, the researchers found that closely connected to subcortical regions showed the most degeneration over the one-year period in PD patients, and that this happens earlier than previously thought.

Their study, published in the journal Nature Communications on Jan. 2, 2018, supports the theory that PD progression is correlated to brain connectivity, thought to be a consequence of propagation of a toxic protein. This work sheds light on the mechanism of Parkinson's Disease and may guide the development and testing of therapeutic interventions.

Explore further: New study maps the progression of Parkinson's disease within the brain

More information: Y. Yau et al. Network connectivity determines cortical thinning in early Parkinson's disease progression, Nature Communications (2017). DOI: 10.1038/s41467-017-02416-0

Related Stories

New study maps the progression of Parkinson's disease within the brain

September 22, 2015
Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the McGill University Health Centre, have made advances in understanding the process involved in the progression and spread ...

Study describes changes to structural brain networks after radiotherapy for brain tumors

June 26, 2017
Researchers compared the thickness of brain cortex in patients with brain tumors before and after radiation therapy was applied and found significant dose-dependent changes in the structural properties of cortical neural ...

Cognitive status doesn't impact cortical A-beta, tau in Parkinson's

December 12, 2017
(HealthDay)—Patterns of cortical β-amyloid (Aβ) and tau are not different for patients with Parkinson's disease (PD) who are cognitively normal (PD-CN) or with mild cognitive impairment (MCI) and for healthy adults, according ...

New study on cerebral astrocytes in depression and suicide

June 2, 2015
A new study published by the team of Naguib Mechawar, Ph.D., a researcher with the McGill Group for Suicide Studies (MGSS) of the Douglas Institute (CIUSSS de l"Ouest-de-l"Ile de Montreal) and associate professor in the Department ...

Brain disconnections may contribute to Parkinson's hallucinations

September 27, 2017
Researchers have found that disconnections of brain areas involved in attention and visual processing may contribute to visual hallucinations in individuals with Parkinson's disease, according to a new study published online ...

Study challenges model of Alzheimer's disease progression

November 4, 2016
Alzheimer's disease is a neurodegenerative disorder for which, despite years of research, there are no effective treatments or cures.

Recommended for you

Two compounds in coffee may team up to fight Parkinson's

December 10, 2018
Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia—two progressive and currently incurable diseases associated with brain degeneration.

New Parkinson's disease drug target revealed through study of fatty acids

December 4, 2018
The human brain is rich in lipids. Investigators studying Parkinson's disease (PD) have become increasingly interested in lipids since both molecular and genetic studies have pointed to the disruption of the balance of the ...

A toxin that travels from stomach to brain may trigger Parkinsonism

December 4, 2018
Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism—symptoms typical of Parkinson's disease like body tremors and slowing of body motions—after the toxin travels ...

Experimental cancer drug shows promise for Parkinson's

December 3, 2018
The study, funded by Parkinson's UK, suggests that the drug, tasquinimod, which is not yet on the market, works by controlling genes that may cause Parkinson's. This happens when the drug interacts with a protein inside brain ...

Parkinson's therapy creates new brain circuits for motor function, study finds

November 28, 2018
Scientists have uncovered that an emerging gene therapy for Parkinson's disease creates new circuits in the brain associated with improved motor movement. These findings, published today in Science Translational Medicine ...

The puzzle of a mutated gene lurking behind many Parkinson's cases

November 15, 2018
Genetic mutations affecting a single gene play an outsized role in Parkinson's disease. The mutations are generally responsible for the mass die-off of a set of dopamine-secreting, or dopaminergic, nerve cells in the brain ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.